In these initial studies, the NOD/SCID mouse (long-term)-repopulating LSC in AML and CML were found to reside preferentially in a CD34+/CD38− subset of the leukemic clone [14,15,16,30]. This evidence concerns the gene CD38 and acute myeloid leukemia.